Oxidative stress in Alzheimer's disease and mild cognitive impairment with high sensitivity and specificity

Journal of Alzheimer's Disease

Volumn 33, Issue 3, 2013, Pages 823-829

  López, Natividad ^a   Tormo, Consuelo ^a   De Blas, Isabel ^b   Llinares, Isabel ^a   Alom, Jordi ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^b Labaqua SA   (Spain)

Author keywords

Alzheimer's disease; copper; malondialdehyde; mild cognitive impairment; oxidative stress

Indexed keywords

BIOLOGICAL MARKER; CERULOPLASMIN; COPPER; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; OXIDATIVE STRESS; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 84872471697     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-121528     Document Type: Article

References (50)

1. Gella A, Durany N (2009) Oxidative stress in Alzheimer disease. Cell Adh Migr 3, 88-93.
2. Mecocci P (2004) Oxidative stress in mild cognitive impairment and Alzheimer disease: A continuum. J Alzheimers Dis 6, 159-163. (Pubitemid 38560251)
3. Sayre LM, Smith MA, Perry G (2001) Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr Med Chem 8, 721-738. (Pubitemid 32427903)
4. Butterfield DA, Drake J, Pocernich C, Castegna A (2001) Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid beta-peptide. Trends Mol Med 7, 548-554. (Pubitemid 33127140)
5. Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfield DA, Markesbery WR (2005) Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 64, 1152-1156.
6. Sies H (1997) Oxidative stress: Oxidants and antioxidants. Exp Physiol 82, 291-295. (Pubitemid 27182306)
7. Zhu X, Su B, Wang X, Smith MA, Perry G (2007) Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci 64, 2202-2210. (Pubitemid 47347959)
8. Jomova K,VondrakovaD,Lawson M,ValkoM(2010) Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 345, 91-104.
9. Kannan K, Jain SK (2000) Oxidative stress and apoptosis. Pathophysiology 7, 153-163.
10. Blokhina O, Virolainen E, Fagerstedt KV (2003) Antioxidants, oxidative damage and oxygen deprivation stress: A review. Ann Bot 91 Spec No, 179-194.
11. Sultana R, Piroddi M, Galli F, Butterfield DA (2008) Protein levels and activity of some antioxidant enzymes in hippocampus of subjects with amnestic mild cognitive impairment. Neurochem Res 33, 2540-2546.
12. Adibhatla RM, Hatcher JF (2010) Lipid oxidation and peroxidation in CNS health and disease: From molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 12, 125-169.
13. Del Rio D, Stewart AJ, Pellegrini N (2005) A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 15, 316-328. (Pubitemid 41190990)
14. Gawel S, Wardas M, Niedworok E, Wardas P (2004) Malondialdehyde (MDA) as a lipid peroxidation marker. Wiad Lek 57, 453-455.
15. Torres LL, Quaglio NB, de Souza GT, Garcia RT, Dati LM, Moreira WL, Loureiro AP, de Souza-Talarico JN, Smid J, Porto CS, Bottino CM, Nitrini R, Barros SB, Camarini R, Marcourakis T (2011) Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 26, 59-68.
16. Valko M, Morris H, Cronin MT (2005) Metals, toxicity and oxidative stress. Curr Med Chem 12, 1161-1208. (Pubitemid 40655271)
17. Huang X, Moir RD, Tanzi RE, Bush AI, Rogers JT (2004) Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann N Y Acad Sci 1012, 153-163. (Pubitemid 38453522)
18. Ozcelik D, Uzun H (2009) Copper intoxication; Antioxidant defenses and oxidative damage in rat brain. Biol Trace Elem Res 127, 45-52.
19. Desai V, Kaler SG (2008) Role of copper in human neurological disorders. Am J Clin Nutr 88, 855S-858S.
20. Castellani RJ, Honda K, Zhu X, Cash AD, Nunomura A, Perry G, Smith MA (2004) Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease. Ageing Res Rev 3, 319-326. (Pubitemid 38849409)
21. Cuajungco MP, Frederickson CJ, Bush AI (2005) Amyloidbeta metal interaction and metal chelation. Subcell Biochem 38, 235-254.
22. Strozyk D, Launer LJ, Adlard PA, Cherny RA, Tsatsanis A, Volitakis I, Blennow K, Petrovitch H, White LR, Bush AI (2009) Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid. Neurobiol Aging 30, 1069-1077.
23. Budimir A (2011) Metal ions, Alzheimer's disease and chelation therapy. Acta Pharm 61, 1-14.
24. Bush AI, Tanzi RE (2008) Therapeutics for Alzheimer's disease based on the metal hypothesis. Neurotherapeutics 5, 421-432. (Pubitemid 351952485)
25. Mates JM, Sanchez-Jimenez F (1999) Antioxidant enzymes and their implications in pathophysiologic processes. Front Biosci 4, D339-D345.
26. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L (2001) Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 58, 397-405. (Pubitemid 32217456)
27. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, TierneyMC, Whitehouse P,Winblad B (2006) Mild cognitive impairment. Lancet 367, 1262-1270.
28. Luis CA, Loewenstein DA, Acevedo A, Barker WW, Duara R (2003) Mild cognitive impairment: Directions for future research. Neurology 61, 438-444. (Pubitemid 37025357)
29. DeCarli C (2003) Mild cognitive impairment: Prevalence, prognosis, aetiology, and treatment. Lancet Neurol 2, 15-21. (Pubitemid 37443340)
30. Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, Smith GE, Jack CR Jr (2009) Mild cognitive impairment: Ten years later. Arch Neurol 66, 1447-1455.
31. Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CR Jr, Galasko DR, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, Jin S, Schultz AN, Schafer K, Mulnard R, van Dyck CH, Mintzer J, Zamrini EY, Cahn-Weiner D, Thal LJ (2004) Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 61, 59-66. (Pubitemid 38067415)
32. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 270-279.
33. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944. (Pubitemid 14076461)
34. Bourdel-Marchasson I, Delmas-Beauvieux MC, Peuchant E, Richard-Harston S, Decamps A, Reignier B, Emeriau JP, RainfrayM(2001) Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing 30, 235-241. (Pubitemid 32684904)
35. Ozcankaya R, Delibas N (2002) Malondialdehyde, superoxide dismutase, melatonin, iron, copper, and zinc blood concentrations in patients with Alzheimer disease: Crosssectional study. Croat Med J 43, 28-32. (Pubitemid 34157862)
36. Polidori MC, Mecocci P (2002) Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease. J Alzheimers Dis 4, 517-522. (Pubitemid 36142841)
37. Gustaw-Rothenberg K, Kowalczuk K, Stryjecka-Zimmer M (2010) Lipids' peroxidation markers in Alzheimer's disease and vascular dementia. Geriatr Gerontol Int 10, 161-166.
38. Padurariu M, Ciobica A, Hritcu L, Stoica B, Bild W, Stefanescu C (2010) Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 469, 6-10.
39. Guidi I, Galimberti D, Lonati S, Novembrino C, Bamonti F, Tiriticco M, Fenoglio C, Venturelli E, Baron P, Bresolin N, Scarpini E (2006) Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 27, 262-269. (Pubitemid 43038550)
40. Wang J, Markesbery WR, LovellMA(2006) Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment. J Neurochem 96, 825-832.
41. Markesbery WR, Kryscio RJ, Lovell MA, Morrow JD (2005) Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol 58, 730-735. (Pubitemid 41552548)
42. Squitti R, Lupoi D, Pasqualetti P, Dal Forno G, Vernieri F, Chiovenda P, Rossi L, Cortesi M, Cassetta E, Rossini PM (2002) Elevation of serum copper levels in Alzheimer's disease. Neurology 59, 1153-1161. (Pubitemid 35192384)
43. Smorgon C, Mari E, Atti AR, Dalla Nora E, Zamboni PF, Calzoni F, Passaro A, Fellin R (2004) Trace elements and cognitive impairment: An elderly cohort study. Arch Gerontol Geriatr Suppl 2004(9), 393-402. (Pubitemid 38822890)
44. Gerhardsson L, Lundh T, Minthon L, Londos E (2008) Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 25, 508-515. (Pubitemid 351957413)
45. Vural H, Demirin H, Kara Y, Eren I, Delibas N (2010) Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease. J Trace Elem Med Biol 24, 169-173.
46. Babiloni C, Squitti R, Del Percio C, Cassetta E, Ventriglia MC, Ferreri F, Tombini M, Frisoni G, Binetti G, Gurzi M, Salinari S, Zappasodi F, Rossini PM (2007) Free copper and resting temporal EEG rhythms correlate across healthy, mild cognitive impairment, and Alzheimer's disease subjects. Clin Neurophysiol 118, 1244-1260. (Pubitemid 46736024)
47. Squitti R, Ghidoni R, Scrascia F, Benussi L, Panetta V, Pasqualetti P, Moffa F, Bernardini S, Ventriglia M, Binetti G, Rossini PM (2011) Free copper distinguishes mild cognitive impairment subjects from healthy elderly individuals. J Alzheimers Dis 23, 239-248.
48. Kharrazi H, Vaisi-Raygani A, Rahimi Z, Tavilani H, Aminian M, Pourmotabbed T (2008) Association between enzymatic and non-Enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease. Clin Biochem 41, 932-936.
49. Rossi L, Squitti R, Pasqualetti P, Marchese E, Cassetta E, Forastiere E, Rotilio G, Rossini PM, Finazzi-Agro A (2002) Red blood cell copper, zinc superoxide dismutase activity is higher in Alzheimer's disease and is decreased by Dpenicillamine. Neurosci Lett 329, 137-140. (Pubitemid 34880058)
50. Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R, Senin U, Mecocci P (2003) Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging 24, 915-919. (Pubitemid 36962976)